Illimis Therapeutics
Developer of protein-based therapeutics designed for the treatment of intractable neurodegenerative diseases. The company's platform leverages proprietary protein engineering and molecular design tech...
Valuation
$0
Share Price
N/A
Total Raised
$64.3M
Last Round
N/A